prognostic indicators

News

Deep Learning Model Accurately Predicts Risk of OS in Gastric Cancer

06/22/2020

A novel deep learning model may accurately predict the risk for overall survival (OS) based on computed tomography (CT) images. Improved risk prediction of OS in gastric cancer is needed in order to guide...

A...

06/22/2020

Journal of Clinical Pathways

News

Predicting Clinical Outcomes of Patients With High-Risk MCL

06/18/2020

Patients with high-risk mantle cell lymphoma (MCL) biology—defined by blastoid variance, Ki-67 greater than 30%, or high p53 immunohistochemistry expression—are more likely to experience shorter failure-free and...

...

06/18/2020

Journal of Clinical Pathways

News

Hypercalcemia as a Biomarker for Aggressive Disease in Patients With B-Cell Lymphoma

05/13/2020

For patients with diffuse large B-cell lymphoma (DLBCL), presence of hypercalcemia at diagnosis correlates with negative prognostic factors and a short diagnosis-to-treatment interval, according to a retrospective...

For...

05/13/2020

Journal of Clinical Pathways

Research in Review

Patients With MCL and a Specific Mutation in Need of Alternative Frontline Therapies

08/21/2017

JCP Editors

Patients with mantle cell lymphoma (MCL) should be stratified based on the status of a specific mutation and considered for alternative first-line therapy, according to a new study published in Blood (online August...

...

08/21/2017

Journal of Clinical Pathways

Research in Review

Pancreatic Cancer Guidelines Do Not Cover Some Targetable Mutations

08/11/2017

JCP Editors

Germline mutations in pancreatic cancer susceptibility genes are often identified in patients with pancreatic cancer without a known family history of cancer, according to a recent study. ----- Related...

...

08/11/2017

Journal of Clinical Pathways

Research in Review

End-of-Life Care Underutilized Among Older Patients With AML

08/10/2017

JCP Editors

Use of end-of-life care and hospice services is suboptimal among older patients with acute myeloid leukemia (AML), according to a recent study published in the Journal of Clinical Oncology (online August 7, 2017;...

Use of...

08/10/2017

Journal of Clinical Pathways

Research in Review

Impact of Vitamin D Deficiency on Relapse in Patients With Myeloid Malignancies

08/10/2017

JCP Editors

Patients with myeloid malignancies who have vitamin D deficiency before undergoing allogeneic stem cell transplantation (alloSCT) are at a higher risk of relapse, according to recent research published in the Journal...

...

08/10/2017

Journal of Clinical Pathways

Research in Review

Novel Ovarian Cancer Subtypes Associated With Survival Outcomes Following Surgery

08/02/2017

JCP Editors

High-grade serous ovarian cancer can be categorized in five molecular subtypes associated with survival and surgical outcomes, according to research published in Clinical Cancer Research (August...

...

08/02/2017

Journal of Clinical Pathways

Research in Review

Prognostic Awareness Affects EOL Decisions, QOL for Cancer Patients

07/21/2017

JCP Editors

Terminally ill patients’ understanding of their prognosis within the last six months of their life often times remain unchanged, according to a recent study. ----- Related Content Oncology care models improve...

...

07/21/2017

Journal of Clinical Pathways

Research in Review

Altered B-Cell Composition May Impact Immunotherapy Effectiveness in AML

07/13/2017

JCP Editors

Initial chemotherapy often alters B-cell composition and immunity in patients with acute myeloid leukemia (AML), which may have implications for the success of further immunotherapy, according to research published...

...

07/13/2017

Journal of Clinical Pathways